関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
嗅覚受容体遺伝子選択は,マウスの嗅覚感覚ニューロンから核移転によってリセットされます
Jinsong Li1, Tomohiro Ishii, Paul Feinstein
1The Rockefeller University, 1230 York Avenue, New York, New York 10021, USA.
Nature
|March 26, 2004
まとめ
ネズミの嗅覚センサーニューロンの嗅覚受容体遺伝子選択は不可逆であり,DNAの再編成によって制御されません. この遺伝子発現は,ゲノム変化なしに,核移転時にリセットされます.
科学分野:
- 神経科学は神経科学である.
- 遺伝学 遺伝学とは
- 嗅覚受容体の研究
背景:
- 哺乳類のゲノムには約1,000の嗅覚受容体 (OR) 遺伝子が含まれています.
- 嗅覚センサーニューロン (OSN) は,典型的には1つのアレルから1つのOR遺伝子を発現します.
- この発現パターンは,リンパ球における免疫グロブリンとT細胞受容体遺伝子調節に似ている.
研究 の 目的:
- DNAの再編成がOSNにおけるOR遺伝子選択を制御するかどうかを調査する.
- OSNにおけるOR遺伝子発現の可逆性とゲノム学的基礎を決定する.
主な方法:
- M71 を発現するOSNs.の永久的な遺伝子マーキング.
- ntES細胞とクローンマウスを生成するためにM71を発現するOSNの核移転.
- ntESの細胞系と派生OSNsのDNA分析.
主要な成果:
- OSNにおけるM71 OR遺伝子選択は,永久的な遺伝子マーキングによって示されているように,不可逆的です.
- M71 を発現するOSNの核転移により,ntES細胞とマウスを生み出した.
- DNA分析は,派生細胞系におけるM71の場所での再配列や配列変化を明らかにしなかった.
- ntES細胞から分化されたOSNは,M71.1.以外のOR遺伝子を発現することができる.
結論:
- OSNにおけるOR遺伝子選択は不可逆的ですが,DNAの再編成は含まれていません.
- OR遺伝子発現パターンは,核移転時にリセットされ,初期選択のための非ゲノムメカニズムを示します.
- ゲノム変異は,OSNにおける不可逆的なOR遺伝子選択に伴わない.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K